FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

213 letters match. Newest first.

  1. GSC Products, LLC

    FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.

    High risk
  2. Aja Health and Wellness Inc.

    FDA warns Aja Health and Wellness that its Aja Migraine Relief nasal spray is an unapproved, misbranded OTC drug.

    Medium
  3. Lus Essentials LLC

    FDA warned Lus Essentials that its Dr. Yanhee skin treatment and lightening products are unapproved, misbranded drugs and contain high mercury.

    High risk
  4. La Crema De Rebeca

    La Crema De Rebeca's skin-lightening cream is an unapproved, misbranded drug containing high mercury, FDA warns.

    High risk
  5. PolleyMed, LLC

    FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.

    High risk
  6. Harbin Jixianglong Biotech Co., Ltd.

    FDA warned Harbin Jixianglong Biotech over CGMP (manufacturing quality rules) failures and misbranded relabeled semaglutide API with false manufacturer labels and missing drug listings.

    High risk
  7. Naveh Pharma LTD/Bigdam Inc.

    FDA says Naveh Pharma and Bigdam sell unapproved saline drug products in the U.S. and have no quality unit.

    High risk
  8. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  9. ProRx LLC

    ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.

    High risk
  10. Ray’s Vitamins

    FDA says Ray's Vitamins sells "Yeicob Ácido Hialurónico" as a supplement, but it is an unapproved, misbranded drug containing hidden diclofenac and dexamethasone.

    High risk
  11. ibeautistore.com

    ibeautistore.com sold Umary hyaluronic acid capsules as a supplement, but FDA found hidden diclofenac, dexamethasone, and omeprazole.

    High risk
  12. Unetixs Vascular, Inc.

    Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.

    High risk
  13. Nature’s Elements, Inc.

    Nature's Elements sold supplement powders with disease claims as unapproved drugs and made them with no required manufacturing records, FDA says.

    High risk
  14. Hearthy Foods, Inc.

    FDA cited Hearthy Foods after an inspection for CGMP violations in RTE whey protein and dietary supplements, including allergen and pest issues.

    High risk
  15. Intelligent Remedies, Inc.

    FDA warned Intelligent Remedies that disease-treatment claims make nine products unapproved new drugs.

    High risk
  16. Diamond-Herpanacine of PA, Inc.

    FDA says Diamond-Herpanacine supplement claims make its eye and skin products unapproved drugs.

    Low
  17. Supersmart USA, LLC

    FDA says Supersmart USA sold dietary supplements with disease-treatment claims, making them unapproved and misbranded drugs.

    Low
  18. Aaa International Seafood Corp.

    Aaa International Seafood Corp. fresh tuna and salmon were adulterated due to seafood HACCP and importer verification failures.

    High risk
  19. Foshan Miwei Cosmetics Co., Ltd.

    FDA warns Foshan Miwei Cosmetics over manufacturing practice failures and unapproved, misbranded over-the-counter (OTC) sunscreen drugs; drugs on import alert.

    High risk
  20. Nupack Inc.

    FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.

    High risk
  21. SaNOtize

    FDA warns SaNOtize that NOWONDER Nasal Cleanser is an unapproved new drug sold in the U.S. with antiviral claims.

    Medium
  22. Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

    FDA found filthy conditions and falsified records at Chinese drug maker Xiamen Kang Zhongyuan; cough drops recalled, imports blocked.

    High risk
  23. RC Outsourcing, LLC

    FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.

    High risk
  24. Medical Products Laboratories, Inc.

    Medical Products Laboratories was cited for manufacturing failures and selling unapproved prescription skin drugs.

    High risk
  25. Beauty of Aztlan LLC

    FDA warns Beauty of Aztlan it sells unapproved, misbranded injectable botulinum toxin drugs online to U.S. consumers.

    High risk
  26. Dry Springs Pharmacy

    FDA warned Dry Springs Pharmacy that its website sells unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  27. Online Rx Medz

    FDA warns Online Rx Medz for selling unapproved, illegally labeled opioids, benzodiazepines, and stimulants online.

    High risk
  28. Rxgoodusa

    FDA warned Rxgoodusa that its website sells unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers without prescriptions.

    High risk
  29. Half Hill Farm Inc.

    FDA cited Half Hill Farm's mushroom extracts as unapproved new drugs over website disease-treatment claims.

    Low
  30. Lovega LLC dba Pink Pony Peptides

    FDA warned Pink Pony Peptides that its GLP-2 TZ, GLP-3 RT and Bacteriostatic Water are unapproved new drugs sold online.

    High risk
  31. Guangzhou Huli Technology Co., Ltd. dba Fantasy Face

    FDA warned Guangzhou Huli Technology (dba Fantasy Face) for selling an unapproved GLP-1 weight loss drug online.

    Medium
  32. Gram Peptides

    Gram Peptides sold unapproved injectable peptide drugs and bacteriostatic water online as new drugs, FDA says.

    High risk
  33. Prime Sciences

    Prime Sciences sells injectable peptide drugs and BAC water online without FDA approval, FDA says.

    High risk
  34. FormPour

    FDA warned FormPour over selling an unapproved new drug, SMGT-GLT-1 Nano Microneedle Patch, on eBay.

    High risk
  35. Mile High Compounds LLC

    FDA warned Mile High Compounds that it sells unapproved injectable GLP-1-like drugs and BAC water online.

    High risk
  36. PekCura Labs

    FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.

    High risk
  37. Yangzhou H&R Plastic Daily Chemical Co., Ltd.

    Yangzhou H&R Plastic Daily Chemical, a Chinese contract manufacturer, lacked release testing and CGMP controls for its OTC drug.

    High risk
  38. ImmunityBio, Inc.

    FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.

    High risk
  39. Citra100mg

    FDA warns Citra100mg it sells unapproved, misbranded tramadol opioids without prescriptions to U.S. consumers online.

    High risk
  40. Apothecary Pharma, LLC

    FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.

    High risk
  41. Premium Health Management Inc. dba Premium Health

    FDA warns Premium Health over misleading website claims for compounded semaglutide and tirzepatide.

    Low
  42. Zeuss LLC dba Zeuss

    FDA warned telehealth seller Zeuss that its website misbrands compounded tirzepatide by implying Zeuss makes it and that it is FDA-approved.

    Medium
  43. Lean Rx, Inc. dba SkinnyRx

    SkinnyRx's website misbranded compounded semaglutide and tirzepatide by wrongly suggesting it makes the drugs and that they are FDA-approved.

    Low
  44. Kare Solutions, LLC dba Zappy

    FDA warned Zappy that its website falsely suggested it compounds semaglutide, tirzepatide, and liraglutide and made misleading approval-like claims.

    Low
  45. Strut Health, LLC dba Strut

    FDA says Strut Health's website falsely labeled compounded semaglutide and tirzepatide as its own and FDA-approved.

    Low
  46. Refills Health, LLC dba Refills Health

    FDA told telehealth seller Refills Health its website misbrands compounded semaglutide by implying FDA approval and naming itself as maker.

    Medium
  47. Weightless Medical LLC dba WeightCare

    FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.

    Low
  48. Viv Health, Inc. dba VIV RX

    FDA warned telehealth company VIV RX that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.

    Medium
  49. Peaks Curative, LLC dba Peaks

    FDA warned Peaks Curative over false or misleading website claims for compounded (pharmacy-made) semaglutide, including implied FDA approval.

    Low
  50. PharmaZee

    FDA warns PharmaZee over misleading website claims for compounded semaglutide and tirzepatide, including implying PharmaZee compounds them and that they are proven.

    Low